Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Germany held the top of the four markets we track for the erythromycin through the first half of the year 2026 (H1 2026), with Q2 closing at a value of USD 79/KG, up 2.6% from the USD 77 in Q1. Worldwide, the average firmed to a value of USD 66/KG in Q2 2026, a gain of just a 3.1% percent over the Q1 figure of USD 64, as the fermentation feedstock costs and the API demand firmed together.
The erythromycin is a macrolide antibiotic active pharmaceutical ingredient, made by the fermentation from the glucose and the starch with the soybean meal. It serves the antibiotic formulations directly and also feeds the routes to the azithromycin and the clarithromycin. Its cost tracks the fermentation feedstock and the energy, and its demand rides the antibiotic and the derivative-API pull.
Two things move the erythromycin price the most: the glucose and the fermentation feedstock costs, and the antibiotic and the derivative-API demand. For the second half of 2026 (H2 2026), a range of an amount of USD 63 to 72/KG looks likely worldwide, supported by the firm macrolide-API offtake.
Supply and the demand look close to balanced through the H2 2026, with the fermentation feedstock costs and the API demand setting the direction. The formulation and the derivative-API buyers held their procurement firm through the H1, and that looks set to hold. China's large fermentation base will likely keep it the cheapest of the four, while the India, the United States, and the Germany track higher on the freight and the local costs.
The market sits set for a firm and a measured move. The bigger question for the buyers is the glucose and the fermentation feedstock cost, since that carries a large part of the finished-API price.
What could push the prices higher? A glucose or an energy cost spike, or a firmer pull from the azithromycin and the clarithromycin routes. What could pull them lower? Softer antibiotic demand, or added low-cost fermentation capacity in the Asia.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 63 - 72 | Firm macrolide-API demand, feedstock-led |
| China | 48 - 56 | Large fermentation base keeps China cheapest |
| India | 57 - 66 | Import-parity pull and firm API demand |
| United States | 73 - 82 | Regulated API demand commands a premium |
| Germany | 77 - 86 | Regulated pharma demand holds the top |
China gained a value of 4.2% to the USD 50/KG, the glucose feedstock cost turning up and the domestic and the export API demand firm. The large fermentation base kept the China the cheapest of the four by a wide stretch.
Why did the price of Erythromycin change in Q2 2026 in China?
The firmer glucose feedstock cost and the firm API demand lifted the offers, though the ample base kept the gain in check.
India moved up a value of 3.5% to the USD 59/KG, the antibiotic and the derivative-API demand steady and the imported feedstock costs firming. The freight kept India above the China through the window.
Why did the price of Erythromycin change in Q2 2026 in India?
The steady antibiotic and the derivative-API demand met the firmer imported feedstock costs and the freight.
The United States firmed a value of 2.7% to the USD 75/KG, the regulated API demand dependable while the fermentation feedstock costs held firm. The demand base held the United States among the priciest of the four.
Why did the price of Erythromycin change in Q2 2026 in United States?
The dependable regulated API demand met the firm fermentation feedstock costs.
Germany gained a value of 2.6% to the USD 79/KG, its regulated pharmaceutical demand holding firm. The compliance and the import-linked costs kept the German prices at the top of the four.
Why did the price of Erythromycin change in Q2 2026 in Germany?
The regulated demand held, and the compliance and the import-linked costs firmed alongside it.
China gained a value of 4.3% to the USD 48/KG, the fermentation feedstock cost firming into the new year and the API buyers restocking after the year-end.
Why did the price of Erythromycin change in Q1 2026 in China?
The firmer glucose feedstock cost met the API restocking as the year opened.
India rose a value of 5.6% to the USD 57/KG, the derivative-API restocking and the firmer imported feedstock costs lifting the delivered prices.
Why did the price of Erythromycin change in Q1 2026 in India?
The derivative-API restocking met the firmer imported feedstock costs into the new year.
The United States firmed a value of 4.3% to the USD 73/KG, the regulated buyers restocking and the feedstock cost lifting the replacement value.
Why did the price of Erythromycin change in Q1 2026 in United States?
The regulated buyers restocked, and the feedstock cost lifted the replacement value.
Germany gained a value of 4.1% to the USD 77/KG, the regulated demand steady and the import-linked costs firming into the new year.
Why did the price of Erythromycin change in Q1 2026 in Germany?
The steady regulated demand met the firmer import-linked costs into the new year.
The global average held a firm path across the window, moving from a value of USD 59/KG in the Q1 2025 to the USD 66 by the Q2 2026, a net gain of about 11.9%. The fermentation feedstock costs and the macrolide-API demand kept the market firm through 2025, and the early 2026 firmed a little faster on the restocking and the glucose costs.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 66 | +3.1% | ↑ Rising |
| Q1 2026 | 64 | +4.9% | ↑ Rising |
| Q4 2025 | 61 | +3.4% | ↑ Rising |
| Q3 2025 | 59 | -1.7% | ↓ Falling |
| Q2 2025 | 60 | +1.7% | ↑ Rising |
| Q1 2025 | 59 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
The year 2025 ran firm for the erythromycin. The global average moved from a value of USD 59/KG in the Q1 to the USD 61 by the Q4, a gain of about 3.4% across the year. The fermentation feedstock costs and the macrolide-API demand held the market firm, with only a shallow Q3 dip, and the year closed near its highs.
Chinese prices moved from a value of USD 44/KG in the Q1 2025 to the USD 46 by the Q4, up about 4.5%. The firm glucose feedstock cost and the export API demand held the market, and China stayed the lowest-cost source of the four all year.
Indian prices firmed from a value of USD 52/KG in the Q1 to the USD 54 by the Q4, a gain of about 3.8%. The antibiotic and the derivative-API demand held steady, and the import lean kept the freight in the delivered price.
The United States prices moved from a value of USD 68/KG in the Q1 to the USD 70 by the Q4, up about 2.9%. The regulated API demand kept the market firm, and the United States held among the priciest of the four all year.
German prices firmed from a value of USD 72/KG in the Q1 to the USD 74 by the Q4, a gain of about 2.8%. The regulated pharma demand kept the market steady, and the compliance and the import costs held Germany the dearest of the four.
Expert Market Research: Your Source for Real-Time Erythromycin Price Intelligence
We keep a continuous watch on the erythromycin prices wherever it is produced or consumed at scale, tracing the causation through the glucose and the fermentation feedstock economics and the antibiotic and the derivative-API demand. Our analysts track all four of the markets on a monthly basis, so the figures reflect the most current data at the time of the publication. Contact Expert Market Research today for the Erythromycin pricing data, the bespoke market analysis, and the strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
The erythromycin is a macrolide antibiotic API. It serves the antibiotic formulations directly and also feeds the routes to the azithromycin and the clarithromycin, with the base (USP) grade carrying most of the regulated volume.
In Q2 2026, it averaged a value of USD 50/KG in China, USD 75/KG in the US, USD 79/KG in Germany, and USD 59/KG in India, on a delivered basis. Germany sat at the top and China priced lowest.
The global average moved from a value of USD 59/KG in the Q1 2025 to the USD 61 by the Q4, a gain of about 3.4%. The fermentation feedstock costs and the macrolide-API demand held the market firm, with only a shallow Q3 dip.
The firm fermentation feedstock costs and the steady antibiotic and derivative-API demand held the market firm through the year.
We expect a global average in a range of an amount of USD 63 to 72/KG for the H2 2026, resting on the firm macrolide-API offtake and the glucose feedstock costs staying near their current range.
Germany sits at the top on the regulated pharma demand and the import-linked freight. The United States holds a firm second on its regulated API demand. India occupies the import-parity middle, and China prices lowest on its large fermentation base.
The glucose and the fermentation feedstock costs matter most, followed by the antibiotic and the derivative-API demand cycles and the pull from the azithromycin and the clarithromycin routes.
China holds the largest fermentation production capacity by a wide margin, with India and parts of the Europe hosting the other established producers. The import-reliant regions carry a freight-adjusted premium over the Asian offers.
Monthly. Need something more current? Our team is available directly.
The quarterly trends and the forecasts help time the API contract talks around the fermentation feedstock cycles, which matters most for the buyers weighing the fixed-price and the index-linked supply.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.